🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

CADASIL Registry Study

Recruitingn/aAges 18 Years - 85 YearsAllBin Cai
NCT04310098 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CADASIL , to optimize clinical management.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Sign informed consent. 2. Age\>18 3. Clinical diagnosis of patients with CADASIL,and confirmed by genetic test or skin biopsy 4. Asymptomatic NOTCH3 mutation carriers 5. Relatives of CADASIL patients or carriers 6. Unrelated healthy controls Exclusion Criteria: 1. Unable to cooperate with inspectors 2. Serious systemic illness, such as heart, liver, kidney disease or major mental illness 3. Contraindications for imaging examination
💊

What it tests

  • Not listed
📍

Where

1 site
Department of Neurology , First Affiliated Hospital Fujian Medical University
Fuzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy